H1-2
Basic information
Region (hg38): 6:26054760-26056470
Previous symbols: [ "H1F2", "HIST1H1C" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the H1-2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 68 | 72 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 68 | 4 | 0 |
Variants in H1-2
This is a list of pathogenic ClinVar variants found in the H1-2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
6-26055794-T-C | not specified | Uncertain significance (Jan 24, 2025) | ||
6-26055806-G-A | not specified | Uncertain significance (Dec 20, 2023) | ||
6-26055815-G-A | not specified | Uncertain significance (Mar 17, 2023) | ||
6-26055816-G-C | not specified | Uncertain significance (Oct 06, 2021) | ||
6-26055825-C-G | not specified | Uncertain significance (Aug 09, 2021) | ||
6-26055828-T-G | not specified | Uncertain significance (Oct 29, 2021) | ||
6-26055845-G-A | not specified | Uncertain significance (Feb 22, 2023) | ||
6-26055846-G-A | not specified | Uncertain significance (Dec 07, 2021) | ||
6-26055855-C-G | not specified | Uncertain significance (Nov 18, 2022) | ||
6-26055863-G-A | not specified | Uncertain significance (Aug 23, 2021) | ||
6-26055866-C-T | not specified | Uncertain significance (Oct 03, 2023) | ||
6-26055879-T-G | not specified | Uncertain significance (Mar 19, 2024) | ||
6-26055885-G-A | not specified | Uncertain significance (Dec 13, 2023) | ||
6-26055890-G-C | not specified | Uncertain significance (Jan 23, 2023) | ||
6-26055908-G-A | not specified | Uncertain significance (Nov 12, 2024) | ||
6-26055911-C-A | not specified | Uncertain significance (Jun 29, 2023) | ||
6-26055912-T-G | not specified | Uncertain significance (Apr 04, 2024) | ||
6-26055918-C-G | not specified | Uncertain significance (Jan 02, 2024) | ||
6-26055924-T-G | not specified | Uncertain significance (May 21, 2024) | ||
6-26055925-C-A | not specified | Uncertain significance (Sep 29, 2023) | ||
6-26055935-G-A | not specified | Uncertain significance (Jul 26, 2022) | ||
6-26055945-C-T | not specified | Uncertain significance (Dec 16, 2024) | ||
6-26055958-T-G | not specified | Uncertain significance (Aug 21, 2024) | ||
6-26055961-C-G | not specified | Uncertain significance (Apr 07, 2023) | ||
6-26055965-G-A | not specified | Uncertain significance (Jul 09, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
H1-2 | protein_coding | protein_coding | ENST00000343677 | 1 | 732 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0275 | 0.592 | 0 | 0 | 0 | 0 | 0.00 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -9.84 | 405 | 112 | 3.62 | 0.00000523 | 1335 |
Missense in Polyphen | 59 | 20.312 | 2.9047 | 275 | ||
Synonymous | -16.9 | 195 | 47.1 | 4.14 | 0.00000241 | 470 |
Loss of Function | 0.101 | 2 | 2.16 | 0.926 | 9.27e-8 | 63 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00 | 0.00 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Histone H1 protein binds to linker DNA between nucleosomes forming the macromolecular structure known as the chromatin fiber. Histones H1 are necessary for the condensation of nucleosome chains into higher-order structured fibers. Acts also as a regulator of individual gene transcription through chromatin remodeling, nucleosome spacing and DNA methylation (By similarity). {ECO:0000250}.;
- Pathway
- Formation of Senescence-Associated Heterochromatin Foci (SAHF);DNA Damage/Telomere Stress Induced Senescence;Cellular Senescence;Cellular responses to stress;Activation of DNA fragmentation factor;Apoptosis induced DNA fragmentation;Apoptotic execution phase;Apoptosis;Programmed Cell Death;Cellular responses to external stimuli
(Consensus)
Recessive Scores
- pRec
- 0.294
Intolerance Scores
- loftool
- 0.483
- rvis_EVS
- -0.22
- rvis_percentile_EVS
- 37.7
Haploinsufficiency Scores
- pHI
- 0.451
- hipred
- hipred_score
- ghis
- 0.429
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.996
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Hist1h1c
- Phenotype
- growth/size/body region phenotype; endocrine/exocrine gland phenotype; cellular phenotype; embryo phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; reproductive system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); limbs/digits/tail phenotype; immune system phenotype;
Gene ontology
- Biological process
- negative regulation of transcription by RNA polymerase II;nucleosome assembly;regulation of transcription, DNA-templated;nucleosome positioning;chromosome condensation;negative regulation of chromatin silencing;negative regulation of DNA recombination;histone H3-K4 trimethylation;histone H3-K27 trimethylation
- Cellular component
- nucleosome;nucleus;nuclear euchromatin;transcriptionally active chromatin
- Molecular function
- double-stranded DNA binding;RNA binding;protein binding;chromatin DNA binding;nucleosomal DNA binding